Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 104,478 | 103,693 | 97,964 | 93,881 | 84,052 |
| Cost of Goods | 2,703 | 513 | 1,040 | 831 | 330 |
| Gross Profit | 101,775 | 103,180 | 96,924 | 93,050 | 83,722 |
| Operating Expenses | 122,169 | 110,864 | 111,839 | 97,497 | 103,504 |
| Operating Income | -19,691 | -7,171 | -14,875 | -3,616 | -19,452 |
| Interest Expense | 3,053 | 3,043 | 3,045 | 3,025 | 7,038 |
| Other Income | 6,950 | 10,518 | 8,226 | 12,725 | 1,669 |
| Pre-tax Income | -15,794 | 304 | -9,694 | 6,084 | -24,821 |
| Income Tax | 14,266 | 481 | 606 | 1,061 | -1,050 |
| Net Income Continuous | -30,060 | -177 | -10,300 | 5,023 | -23,771 |
| Net Income | $-30,060 | $-177 | $-10,300 | $5,023 | $-23,771 |
| EPS Basic Total Ops | -0.61 | 0.00 | -0.20 | 0.10 | -0.47 |
| EPS Basic Continuous Ops | -0.60 | 0.00 | -0.20 | 0.10 | -0.47 |
| EPS Diluted Total Ops | -0.61 | 0.00 | -0.20 | 0.10 | -0.47 |
| EPS Diluted Continuous Ops | -0.59 | 0.00 | -0.20 | 0.10 | -0.47 |
| EPS Diluted Before Non-Recurring Items | -0.60 | 0.00 | -0.20 | 0.10 | -0.47 |
| EBITDA(a) | $-18,857 | $-6,373 | $-14,095 | $-2,762 | $-18,286 |